GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Buildings And Improvements

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Buildings And Improvements : ¥0 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Buildings And Improvements?

Zhejiang Garden Biopharmaceutical Co Buildings And Improvements Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Buildings And Improvements Chart

Zhejiang Garden Biopharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhejiang Garden Biopharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zhejiang Garden Biopharmaceutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Zhejiang Garden Biopharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Buildings And Improvements
Comparable Companies
SHSE:688131 SZSE:300363 SZSE:002550 SZSE:002275 SHSE:600252 SHSE:688091 SHSE:688276 SZSE:000756 SHSE:601089 SZSE:000650 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018
Website
http://www.hybiotech.com
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Executives
Shao Xu Jun Director
Liu Xiao Ping Executives
Shao Qin Xiang Director
Shao Jun Fang Director
Liu Jian Gang Directors, executives
Qian Guo Ping Executives
Zhu Jian Xing Supervisors
Yu Quan Heng Directors, executives, directors
Ma Huan Zheng Directors, executives
Li Hui Ying Supervisors
Ma Wen De Director
Chen Yi Executives
Gu Yi Kang Independent director

Zhejiang Garden Biopharmaceutical Co Headlines

No Headlines